U.S. flag

An official website of the United States government

New/Reinstated & Terminated Labeler Information

The information below identifies new/reinstated & terminated labelers. This page will be updated as new information is available so please check back often.

For definitions of optional and mandatory effective dates, please see the Medicaid National Drug Rebate Agreement (NDRA). Additionally, the Drug Manufacturer Contact Information contains Optional Effective Date, Termination Date (if applicable), and Legal, Invoice and Technical Contact information for each drug company participating in the MDRP. 

New/Reinstated Labelers

Labeler Code Labeler Name Optional Effective Date (for State Coverage) Mandatory Effective Date (for State Coverage)
73063 AMYLYX PHARMACEUTICALS 11/22/2022 04/01/2023
81288 EMC PHARMA, LLC 11/16/2022 04/01/2023
76961 SPECTRUM PHARMACEUTICALS, INC. 11/09/2022 04/01/2023
82429 GABAR HEALTH SCIENCE 10/26/2022 01/01/2023
81968 AXSOME THERAPEUTICS, INC. 10/20/2022 01/01/2023
73077 FENNEC PHARMACEUTICALS, INC. 10/19/2022 01/01/2023
65086 SANTEN, INC. 10/07/2022 01/01/2023
69681 VERU INC. 09/28/2022 01/01/2023
82249 CIVICASCRIPT, LLC 09/26/2022 01/01/2023
81665 OMNIVIUM PHARMACEUTICAL 09/20/2022 01/01/2023
81298 LONG GROVE PHARMACEUTICALS, LLC 09/12/2022 01/01/2023
81140 PROTEGA PHARMACEUTICALS LLC 09/07/2022 01/01/2023
80735 CIPLA THERAPEUTICS INC. 09/02/2022 01/01/2023
81583 MARINUS PHARMACEUTICALS INC. 08/25/2022 01/01/2023
73683 NOBELPHARMA AMERICA, LLC 08/25/2022 01/01/2023
82293 NOVUGEN PHARMA (USA) LLC 08/19/2022 01/01/2023
80610 ARCUTIS BIOTHERAPEUTICS, INC. 08/18/2022 01/01/2023

Terminated Labelers

Labeler Code Labeler Name Effective Date
73320 KARTHA PHARMACEUTICALS 01/01/2023
69087 CLARUS THERAPEUTICS, INC. 01/01/2023
65293 THE MEDICINES COMPANY 01/01/2023
52565 TELIGENT PHARMA, INC. 01/01/2023
52440 TITAN PHARMACEUTICALS, INC. 01/01/2023
00299 GALDERMA LABORATORIES, L.P. 01/01/2023
00225 B. F. ASCHER AND COMPANY, INC. 01/01/2023
62541 VIVUS LLC 01/01/2023
55792 LUKARE MEDICAL, LLC 01/01/2023

For questions, please contact MDRP Operations at MDROperations@cms.hhs.gov.

Disclaimer: Please note that the information provided on this web page does not bind or obligate the Centers for Medicare and Medicaid Services (CMS). The statements included on this web page are intended to provide information on New/Reinstated & Terminated Labelers and do not in any way revise or modify the requirements set forth in Section 1927 of the Act, the national drug rebate agreement (NDRA), subsequent program releases, or regulations.

Page last updated on December 1, 2022